Literature DB >> 12698642

Endobronchial therapy of neoplasms.

Michael Unger1.   

Abstract

The techniques and modalities provided by interventional pulmonology play a major role in the management of patients with symptomatic airways obstruction. The majority of these obstructions are part of pulmonary involvement by primary lung neoplasms or metastatic lesions from other organs. Benign lesions, although capable of producing similar symptoms, are more rare. Performance of successful interventional pulmonology is dependent on the skill and dexterity of the operator paired with a highly trained and dedicated ancillary team of nurses, anesthetists, and respiratory therapists. Successful endobronchial management of airway obstruction not only provides significant improvement in patients' quality of life, it also adds to their survival time. Both results fulfill the stated goals of appropriate and desired palliative therapy. Interventional pulmonology also contributes to research of the process of lung carcinogenesis and the introduction of targeted therapy for early minimally invasive cancer and the potential chemotherapy of premalignant lesions.

Entities:  

Mesh:

Year:  2003        PMID: 12698642     DOI: 10.1016/s1052-3359(02)00041-8

Source DB:  PubMed          Journal:  Chest Surg Clin N Am        ISSN: 1052-3359


  3 in total

1.  Rigid bronchoscopic interventions for central airway obstruction - An observational study.

Authors:  Ajmal Khan; Zia Hashim; Mansi Gupta; Hira Lal; Aarti Agarwal; Alok Nath
Journal:  Lung India       Date:  2020 Mar-Apr

2.  Small cell lung cancer with endobronchial growth: A case report.

Authors:  Koichi Kurishima; Katsunori Kagohashi; Kunihiko Miyazaki; Tomohiro Tamura; Gen Ohara; Mio Kawaguchi; Hiroaki Satoh
Journal:  Oncol Lett       Date:  2013-06-25       Impact factor: 2.967

3.  Superficial-type endobronchial metastases from colon cancer: A case report.

Authors:  Koichi Kurishima; Hiroaki Satoh; Katsunori Kagohashi; Kunihiko Miyazaki; Tomohiro Tamura; Toshihiro Shiozawa; Gen Ohara; Mio Kawaguchi; Norio Takayashiki; Nobuyuki Hizawa
Journal:  Oncol Lett       Date:  2014-08-21       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.